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Abstract
Mechanisms of bone formation and skeletal development have been successfully investigated in zebrafish using
a variety of in vivo approaches, but in vitro studies have been hindered due to a lack of homologous cell lines
capable of producing an extracellular matrix (ECM) suitable for mineral deposition. Here we describe the
development and characterization of a new cell line termed ZFB1, derived from zebrafish calcified tissues. ZFB1
cells have an epithelium-like phenotype, grow at 28C in a regular L-15 medium supplemented with 15% of fetal
bovine serum, and are maintained and manipulated using standard methods (e.g., trypsinization, cryopreser-
vation, and transfection). They can therefore be propagated and maintained easily in most cell culture facilities.
ZFB1 cells show aneuploidy with 2n= 78 chromosomes, indicative of cell transformation. Furthermore, because
DNA can be efficiently delivered into their intracellular space by nucleofection, ZFB1 cells are suitable for gene
targeting approaches and for assessing gene promoter activity. ZFB1 cells can also differentiate toward osteo-
blast or chondroblast lineages, as demonstrated by expression of osteoblast- and chondrocyte-specific markers,
they exhibit an alkaline phosphatase activity, a marker of bone formation in vivo, and they can mineralize their
ECM. Therefore, they represent a valuable zebrafish-derived in vitro system for investigating bone cell differ-
entiation and extracellular matrix mineralization.
Introduction
Bone diseases are one of the most prevalent patholo-gies in the human population, particularly incident in
elderly populations, throughout life and can affect bone
formation, mineralization, and/or remodeling. In the past
decades, most studies aiming at deciphering the complex
mechanisms of vertebrate bone homeostasis have been per-
formed using various animal models such as mammals1–4
and chicken.5–7 Those mechanisms remain, however, insuf-
ficiently understood and the use of alternative vertebrate
models such as fish have been proposed to bring new in-
sights. Because of the high evolutionary conservation of
molecular mechanisms and physiological features among
vertebrates, as well as the various technical advantages over
mammals (e.g., external and rapid development and trans-
parent embryos),8–11 teleost fish are recognized as suitable
models to study the underlying mechanisms of bone for-
mation and mineralization during skeletogenesis.12–17 Re-
generative capacities of fish (in particular, bony rays of the
caudal fin) have also validated this model for studies related
to bone formation and repair.18–20 The zebrafish, Danio rerio
(Hamilton, 1822), is among the most popular fish model; it is
widely used for developmental and functional studies21,22
and is already used as an in vivo model of several human
bone diseases—for example, osteogenesis imperfecta,13 cra-
niofacial dysplasia,16,23 holospondyly24—and to study the
role played by various genes in bone formation, homeosta-
sis, skeletal development, and deformities.13,25–29 However,
studies with zebrafish in the field of bone biology have been
hampered by the absence of in vitro cell systems suitable to
study the cellular mechanisms associated with bone cell
(e.g., osteoblasts and chondrocytes) differentiation and ex-
tracellular matrix (ECM) mineralization. During the last
decades, few zebrafish cell lines have been generated,30–35
mostly derived from embryonic tissues and none of them
were reported to be capable of in vitro mineralization. We
describe here the establishment, for the first time, of a stable
cell culture derived from a pool of zebrafish calcified tissues
and the characterization of its mineralogenic capacity by
histological staining, immunocytochemistry, and gene ex-
pression analysis.
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Materials and Methods
Zebrafish maintenance
Wild-type zebrafish were maintained in 10-L aquaria with
water recirculation (ZebTec housing System; Tecniplast)
under the following conditions: temperature, 28C; photope-
riod, 14/10-h light/dark; pH, 7.5; conductivity, 660 lS; den-
sity, two fish L- 1. Fish were fed twice a day with dry food
(Tetramin flake C) and live Artemia nauplii.
Tissue collection and processing
Three-month-old healthy zebrafish ranging from3 to 4 cm in
lengthwere given a lethal anesthesia of 0.015% tricaine (Sigma-
Aldrich). Calcified tissues, that is, vertebra, upper and lower
jaws, and branchial arches, were collected aseptically from four
zebrafish and cleaned from adherent tissues in phosphate-
buffered saline (PBS; pH 7.4) supplemented with 500 IU/mL of
penicillin and 500lg/mL of streptomycin (Invitrogen). Tissues
were minced into small pieces (*8mm3) using sterile instru-
ments and fragments were placed in 25-cm2 cell culture flasks
(Sarstedt) containing 3mL of the Leibovitz’s L-15 medium
supplemented with 20% fetal bovine serum (FBS), 100 IU/mL
of penicillin, 100lg/mL of streptomycin, and 2.5lg/mL of
fungizone (all from Invitrogen). Cells were then allowed to
migrate from fragments and to adhere to the surface of the flask
for 2 weeks at 28C. The culture mediumwas replaced every 5
days. At confluence, cells were subcultured (1:2) using 0.25%
trypsin (Invitrogen) and 0.2% EDTA in PBS.
Chromosome analysis
Cell cultures at passage 43 were exposed for 2h to colchicine
(0.0025% in PBS; Sigma-Aldrich). Cells were detached using
trypsin-EDTA and harvested by centrifugation (2000 g for
3min). Cell pellets were gently resuspended in 0.027M KCl in
PBS and incubated at 25C for 30min. Cells were harvested
again and fixed in a freshly preparedmixture of cold methanol/
acetic acid (3:1) for 15min. After three washes in fixative, cells
were resuspended in a small quantity of fixative, then drop-
ped onto cold glass slides, air-dried, and stained with 5%
Giemsa (pH 6.8; Merck Chemicals) for 20min. Chromosomes
were counted from micrographs of 50 metaphase plates.
Cryopreservation
ZFB1 cells from subconfluent cultures were harvested by
centrifugation (2000 g for 5min) and resuspended in an ice-
cold medium supplemented with 10% cell culture grade di-
methyl sulfoxide (Sigma-Aldrich) at a density of 106 cells/mL.
Cell suspensions were dispensed into 2-mL cryotubes (Sar-
stedt), placed at - 80C in a cell freezing device (Nalgene)
overnight, and then transferred into liquid nitrogen. Frozen
cells were recovered in 9mL of the culture medium and
placed in a flask at 28C. The medium was renewed after 8 h
and cell viability was determined using the Trypan blue dye
exclusion method.36
Cell proliferation
Cells were seeded at a density of 1.5 · 103 cells/well in 96-
well plates and proliferation was determined at appropriate
times using the CellTiter 96 Non-Radioactive Proliferation
Assay kit (Promega).
Transfection
Transfection efficiency of ZFB1 cells was determined using
pEGFP-N1 (Clontech) or pmaxGFP (Lonza) vectors expres-
sing the green fluorescent protein (GFP) under the control of a
CMV promoter. ZFB1 cells were seeded at a density of 5· 105
cells/well in 6-well plates and cultured until subconfluence.
The pEGFP-N1 vector (1 lg) was delivered into the cells using
FuGENE6 or FuGENE-HD (both fromRoche) according to the
manufacturer’s instructions, through calcium phosphate co-
precipitation according to Pfitzner et al.37 or using poly-
ethylenimine (PEI) according to Braga et al.38 The pmaxGFP
vector was delivered into the cells through nucleofection. In
this case, 6· 105 cells were resuspended in 100lL of buffer L
or V (Nucleofection optimization kit; Lonza) and nucleofected
with 2lg of the pmaxGFP vector using the Amaxa Nucleo-
fector (Lonza). Cells were seeded into 6-well plates and
incubated for 6 h at 28C. The culture medium was changed
48 h after transfection and 6 h after nucleofection, and effi-
ciency of DNA delivery was determined by flow cytometry
(BD Biosciences).
ECM mineralization
Cells were seeded at a density of 105 cells/well in 6-well
plates and grown to confluence. ECM mineralization was
induced by supplementing the culture medium with a mi-
neralogenic cocktail composed of 10mM b-glycerophosphate,
4mM calcium chloride, and 50lg/mL of L-ascorbic acid.39
The medium was changed twice a week. After 3 weeks of
treatment, levels of mineralization were assessed through
Alizarin Red S (AR-S, 40mM at pH 4.2; Sigma-Aldrich) and
von Kossa’s (VK) stainings.40
Proteoglycan production
Cells were seeded at a density of 105 cells/well in 6-well
plates and grown to confluence. Proteoglycan production was
induced by supplementing the culture medium with 6.25 lg/
mL of human insulin, 50 nM ascorbate 2-phosphate, and
10 ng/mL of human transforming growth factor-b1 (all from
Sigma-Aldrich). After 3 weeks of treatment, the presence of
proteoglycans was assessed through Alcian Blue 8GS staining
(0.5% [w/v] in 0.1N HCl at pH 1.0; Sigma-Aldrich).
Alkaline phosphatase activity
Cells were seeded at a density of 3 · 105 cells/well in 6-
well plates and grown under mineralizing or normal condi-
tions. At appropriate times, cells were washed with PBS,
fixed in a 1% (v/v) glutaraldehyde solution (prepared in
PBS) for 10min, washed twice with PBS, and then incubated
(in the dark) in a solution containing 50mg/mL of bromo-
chloro-indolyl phosphate/nitroblue tetrazolium (BCIP/NBT;
Sigma-Aldrich). The development of a blue signal indicative
of an alkaline phosphatase (ALP) activity was observed by
microscopy. At appropriate times, the ALP activity was also
measured in cell extracts by spectrophotometry according to
the method described by Tiago et al.41
Immunofluorescence staining
For immunophenotyping, cells were grown on 13-mm
glass coverslips (VWR), fixed with 3.7% (v/v) formalin
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(prepared in PBS) for 10min at 4C, washed with PBS, per-
meabilized with 0.1% Triton X-100 for 5min, and blocked in
PBS containing 1% bovine serum albumin (BSA). Mouse
monoclonal antibodies (Developmental Studies Hybridoma
Bank) against Spp1/osteopontin (MPIIIB10-1), type II colla-
gen (II-II6B3), type X collagen (X-AC9), and chondroitin sul-
fate proteoglycans (9BA12), were diluted 1:10 in PBS with 1%
BSA and directly added to the fixed cells at room temperature
for 2 h. Cells were washed with 1:10 dilution of a blocking
buffer in PBS and incubated with a Alexa Fluor 594-linked
secondary antibody (Invitrogen) for 45min at room temper-
ature in the dark. Cells were washed several times with PBS,
mounted in Mowiol (Sigma-Aldrich), and observed using an
Olympus IX81 motorized fluorescence microscope equipped
with an F-View camera (Olympus).
Immunohistochemistry
The suitability of mouse monoclonal antibodies against
type II collagen and chondroitin sulfate proteoglycans for
detecting zebrafish proteins was determined through whole-
mount immunohistochemistry and staining of 6- to 7-cm-long
zebrafish larvae, according to the procedure described by
Verstraeten et al.42 Control fish were treated with a secondary
antibody alone.
Western blot analysis
The suitability of mouse monoclonal antibodies against
type X collagen and osteopontin/Spp1 for detecting zebrafish
proteins was determined through western blot analysis
of proteins prepared from zebrafish vertebrae and mouse fe-
mur. Protein extracts were fractionated on 4%–12% acrylamide
NuPAGENovex Bis-Tris gels (Invitrogen) and transferred onto
PVDF membranes (Millipore) using the XCell SureLock blot
module (Invitrogen). Chemiluminescence of the anti-mouse
IgG-peroxidase conjugate (Sigma-Aldrich; 1:30,000 dilution)
was detected using the Western Lightning ECL kit (Perkin
Elmer) and Hyperfilm ECL (Amersham, GE Healthcare).
RNA preparation and gene expression analysis
Total RNA was extracted from cell cultures according to
Chomczynski and Sacchi.43 RNA integrity was assessed
through 1% (w/v) agarose/formaldehyde gel electrophoresis
and RNA quantity was determined through spectrophoto-
metry (NanoDrop 1000; Thermo Scientific). Total RNA (1 lg)
was treated with RNase-free DNase I (Promega) for 30min
at 37C and reverse transcribed at 37C for 1 h using the
Moloney-murine leukemia virus (M-MLV) reverse tran-
scriptase (Invitrogen), RNase Out (Invitrogen), and oligo-d(T)
[5¢-ACGCGTCGACCTCGAGATCGATG(T)13-3¢]. Levels of
gene expression were determined through real-time PCR
amplification carried out using gene-specific primers (Sup-
plementary Table S1; Supplementary Data are available on-
line at www.liebertpub.com/zeb) and normalized using the
eef1a1l1 housekeeping gene. A reaction mixture containing
1· Sso Fast EvaGreen supermix (Bio-Rad), 10 lM of forward
and reverse primers, and 1:10 dilution of reverse-transcribed
RNA was submitted to the following PCR conditions: 2min at
95C and 50· (20 s at 95C, 45 s at 68C). Amplifications were
performed by using the StepOnePlus Real-Time PCR system
(Applied Biosystems).
Results and Discussion
Establishment of ZFB1 cells
Several primary cell cultures derived from zebrafish-
calcified tissue explants were developed as described in
the Materials and Methods section and cultured at 28C in
the L-15 medium supplemented with 20% (until passage 30)
and then 15% FBS. One culture—named ZFB1—was se-
lected based on morphological criteria and mineralogenic
potential and further characterized. After few passages,
ZFB1 cells exhibited a polygonal shape and an epithelial-
like phenotype (Fig. 1A) and growth appeared to be contact
inhibited; this phenotype was maintained for more than 70
passages. The cell monolayer was routinely dissociated
every 3–5 days using trypsin-EDTA and divided 1:2. The L-
15 medium/FBS appeared to be adequate to sustain the
growth of ZFB1 cells without the need for adjustments (e.g.,
osmolality and pH) or further supplements (e.g., fish se-
rum). Whereas previous reports on the development of
mineralogenic cell lines from marine teleosts39 mentioned
the use of an enzymatic cocktail to digest the bone collag-
enous matrix (collagenase) and cleave proteins anchoring
bone cells to the matrix (trypsin), thus facilitating migration
of bone cells from explants, ZFB1 cell culture was developed
without any enzymatic treatment of bone fragments. The
only apparent consequence was a slight delay in the initial
cell migration from tissue fragments.
Proliferation of ZFB1 cells was assessed in the presence of
four different FBS concentrations. While increasing FBS con-
centration to 20% (concentration used for the explant culture
and the initial steps of the primary cell culture) did not im-
prove the proliferation rate of ZFB1 cells, decreasing it to 10%
and 5% significantly reduced cell growth rate by 15% and
75%, respectively (Fig. 1B). It is noteworthy that although 10%
of serum will not bring optimal culture conditions, it will
sustain cell proliferation to levels suitable for most in vitro
experimentation.
Cryopreservation of ZFB1 cells at passage 45 was success-
fully achieved using methods developed for mammalian cells
and applied previously in our laboratory to marine fish cell
lines.44 Approximately 80% of ZFB1 cells survived cryopres-
ervation in 10% DMSO and actively divided thereafter (re-
sults not shown).
Ploidy of ZFB1 cells was determined at passage 43
from chromosome counting in 50 metaphase plates. While
diploid number of chromosome is 2n = 50 in zebrafish, a
modal number of 78 chromosomes was observed in ZFB1
cells (Fig. 1C), indicating aneuploidy. Occurrence of
abnormal number of chromosomes is frequent in cell lines,
particularly in fish,45 and is considered to be a sign of cell
transformation.46
DNA delivery into ZFB1 cells at passage 40 was assayed
through lipofection, nucleofection or using polymers, and
was evaluated through GFP fluorescence. While lipofec-
tion and polymer-assisted transfection resulted in few GFP-
positive cells (efficiency ranged from 1% using calcium
phosphate coprecipitation to 22% using FuGENE-HD), nu-
cleofection proved to be an efficient method for delivering
DNA into ZFB1 cells (efficiency was up to 72%; Fig. 1D). In
combination with nucleofection, ZFB1 cells represent a valid
tool for successful gene or mRNA targeting approaches and
for assessing gene promoter activity.
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ECM mineralization and production
of sulfated proteoglycans
Mineralization of ZFB1 ECM was induced by supple-
menting the culture medium with a mineralogenic cocktail
and evidenced through the presence of numerous calcium
phosphate deposits of various sizes, found to be positive for
VK and AR-S staining (Fig. 2A, D, respectively). No clear
mineral deposits were observed in cultures left untreated
(Fig. 2B, E, respectively) indicating the requirement for an
osteogenic stimulus to trigger cell differentiation, and none
was observed in the absence of cells (results not shown)
indicating a cell-mediated process. ECMmineralization was
further quantified through densitometry (VK; Fig. 2C) and
spectrophotometry (AR-S; Fig. 2F) analysis. These results
demonstrated the ability of ZFB1 cells in differentiating to-
wards an osteoblastic phenotype and in producing a matrix
compatible with in vitro mineralization, as reported previ-
ously for marine fish cell lines.39,47 ZFB1 cell cultures ex-
posed for 1 week to the mineralogenic cocktail exhibited a
strong ALP activity (Fig. 2G) further confirmed through
enzymatic assays of ALP activity (Fig. 2I). However, it was
not significantly different from that observed in untreated
cells (Fig. 2H) suggesting an acquired capacity to express
high levels of ALP affecting positively the predisposition
of these cells to differentiate towards an osteoblastic-like
phenotype.
While mineralization of osteoblast matrix in rat, mouse and
human only requires medium supplementation with ascorbic
acid and b-glycerophosphate,48–53 fish osteoblast cells need a
source of calcium (usually calcium chloride) to achieve ECM
mineralization.39,54 No deposition of mineral was detected by
VK staining in ZFB1 cell cultures exposed to a mineralogenic
cocktail lacking calcium, even after extended periods of
treatment (results not shown). This suggests that the quantity
of calcium initially present in the culture medium (0.1396 g/L
or 1.8mM) is not sufficient to trigger the formation of calcium
phosphate crystals during osteoblastic differentiation of zeb-
rafish cells. We propose that calcium is a general requirement
for ECM mineralization in fish mineralogenic cell lines and
that this is probably the consequence of the presence of high
levels of calcium in fresh and sea water (averaged value are
about 4 and 400mg/L, respectively) and the need for a higher
plasma calcium concentration in fish as a stimulus for initi-
ating ECM mineralization.39
Confluent cultures of ZFB1 cells were also treated for 3
weeks with a chondrogenic cocktail containing transforming
growth factor-b1, a key factor in the regulation of cellular
differentiation in cartilage formation.55 Upon treatment, ZFB1
FIG. 1. Characterization of ZFB1 cells. (A) Phase-contrast
micrographs of confluent cultures of zebrafish ZFB1 cells at
passages (P) 15, 30, and 45. (B) Proliferation of passage 37
ZFB1 cells cultured for 12 days in a medium supplemented
with different FBS concentrations. Gray bar indicates the
concentration originally used to develop the cells. Asterisks
indicate values statistically significant from 15% FBS value
(one-way ANOVA, Dunnett’s test; **p < 0.001; ***p < 0.0001).
(C) The chromosome number of ZFB1 cells at passage 43.
Chromosomes were counted manually from 50 metaphase
plates. Gray bar indicates a modal number of 78 chromo-
somes. (D) Efficiency of DNA delivery into ZFB1 cells as-
sessed through GFP fluorescence. Insert shows the GFP
signal in ZFB1 cells nucleofected using the buffer L and
program 5 (L-5). FG-6, FuGENE 6; FG-HD, FuGENE HD;
PEI, polyethylenimine; Ca/P, calcium phosphate coprecipi-
tation; NF, nucleofection; GFP, green fluorescent protein.
Scale bar is 200 lm in (A) and 100lm in insert (D).
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cells condensed into three-dimensional aggregates and pro-
duced highly sulfated proteoglycans, evidenced through Al-
cian Blue staining (Fig. 2J) and further confirmed through
spectrophotometry analysis (Fig. 2L). No Alcian Blue staining
was observed in cultures left untreated (Fig. 2K). These results
demonstrate the ability of ZFB1 in differentiating towards a
chondroblastic phenotype and producing a cartilaginous
matrix. Similar results have been reported by Ogawa et al.56 in
a study where adipose-derived stem cells (cells with a mes-
enchymal origin, similar to chondrocytes and osteoblasts)
FIG. 2. Extracellular matrix (ECM) mineralization (A-F), ALP activity (G-I) and sulfated proteoglycan production ( J-L) in
ZFB1 cells at passage 45. (A) Phase-contrast micrographs of VK-stained cells treated for 3 weeks with osteogenic cocktail.
Mineral nodules appear in black. (B) Untreated cells. (C) Levels of ECM mineralization by densitometry analysis of VK’s
staining after 3 weeks of treatment. (D) Phase-contrast micrographs of AR-S-stained cells treated for 3 weeks with osteogenic
cocktail. Mineral nodules appear in red. (E) Untreated cells. (F) Levels of ECM mineralization by spectrophotometry analysis
of AR-S staining after 3 weeks of treatment. (G) Phase-contrast micrographs of mineralizing cell cultures stained for alkaline
phosphatase activity (purple). (H) Untreated cells. (I) Levels of ALP activity in 1 week of mineralizing cell cultures. ( J) Phase-
contrast micrographs of Alcian Blue-stained cells treated for 3 weeks with chondrogenic cocktail. Sulfated proteoglycans
appear in blue (arrowhead). (K) Untreated cells. (L) Levels of sulfated proteoglycans determined by spectrophotometry
analysis of AB staining after 3 weeks of treatment. ND, not detectable. Scale bar is 200lm. VK, von Kossa; AR-S, Alizarin
Red; ALP, alkaline phosphatase. Color images available online at www.liebertpub.com/zeb
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treated with transforming growth factor-b1 resulted in three-
dimensional aggregates positively stained with Alcian Blue.
Based on the above results we propose that ZFB1 cells have
the capacity to differentiate towards osteoblast and chon-
droblast lineages upon appropriate stimulation. This was
further confirmed by immunocytochemistry using antibodies
specific for cartilage-associated proteins including Cspgs
(chondroitin sulfate proteoglycans) and Col2a1 (collagen,
type II, alpha 1) (Fig. 3A, C respectively). These proteins were
located mostly at sites of cell condensation and deposit of
mineralization-related proteins including Spp1 (secreted
phosphoprotein 1/osteopontin) and Col10a1 (collagen, type
X, alpha 1) (Fig. 3E, G respectively). No signal was detected in
cells at week 0 (i.e., prior to treatment, data not shown). Po-
sitive staining for all markers was observed after 1 week (data
not shown) and 3 weeks (Fig. 3) of treatment. Treated and
untreated cultures, as well as negative controls, are shown in
Supplementary Figure S1. To confirm the suitability of mouse
antibodies to detect zebrafish proteins, whole-mount immu-
nohistochemistry using zebrafish larvae (for Cspgs and
FIG. 3. Osteochondroblastic
differentiation of ZFB1 cells
and detection of lineage-
specific markers by immuno-
cytochemistry. (A) Chondroitin
sulfate proteoglycans/Cspgs.
(B) Differential interference
contrast (DIC) image of (A).
(C) Collagen type II/Col2. (D)
DIC image of (C). (E) Osteo-
pontin/Spp1. (F) DIC image
of (E). (G) Collagen type X/
Col10. (H) DIC image of (G).
In all micrographs, the nu-
cleus is stained with DAPI
(green). Scale bar is 10lm.
Color images available online
at www.liebertpub.com/zeb
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Col2a1) andwestern blotting comparingmouse and zebrafish
vertebra extracts (for Col10a1 and Spp1) were performed
(Supplementary Fig. S2), thus validating the use of these an-
tibodies in our study.
Gene expression during in vitro mineralization
of ZFB1 cells
Expression of several bone-related genes was evaluated by
qPCR in ZFB1 cell cultures undergoing osteoblast differenti-
ation (1 week) and ECM mineralization (3 weeks) and com-
paredwith control cells (Fig. 4). Alp is thought to play a role in
the early mineralization process through the break-down of
pyrophosphate, a known inhibitor of tissue mineralization,57
thus inducing production of phosphate groups for crystal
formation.58 While alp expression was down-regulated in
control cells at both time points, it was up-regulated in cells
undergoing osteoblastic differentiation (approximately 2-
fold increase over control) and down-regulated in cells un-
dergoing ECM mineralization to levels found in control cells.
In agreement with previous reports,59 Alp seems to play a
more important role during ZFB1 cell differentiation and
matrix production than during ECM mineralization. Runt-
related transcription factor 2 (Runx2) and osterix (Osx)
are two transcription factors involved in osteoblast differen-
tiation and bone formation in mammals60,61and in fish.62
Expression of both genes was stable in control cells and
strongly up-regulated in cells undergoing differentiation (2.7
and 5-fold increase at 1 and 3 weeks, respectively) and ECM
mineralization (13.3 and 66.5-fold increase, at 1 and 3 weeks
respectively) upon exposure to the mineralogenic cocktail.
Osteopontin (Spp1) and osteonectin (Sparc) are two non-
collagenous proteins present in osteoblast ECM.63,64 Spp1 is a
highly phosphorylated sialoprotein and a prominent com-
ponent of bone and teeth mineralized ECM,65 while Sparc is a
matricellular glycoprotein with calcium binding domains
which has been associated with ECM mineralization in oste-
oblasts.66 These two proteins play a role in the regulation of
mineralization,63 attachment of osteoblasts and osteoclasts to
the bone matrix, and/or attraction of cells to the bone ma-
trix.67 Expression of both genes was stable in control cells
and up-regulated in cells undergoing differentiation (1.8 and
1.4-fold increase at 1 and 3 weeks, respectively) and ECM
mineralization (9.3 and 3.7-fold increase, at 1 and 3 weeks re-
spectively) upon exposure to the mineralogenic cocktail. While
an increase in spp1 expression in differentiating ZFB1 cells is in
agreement with previous reports in mammalian68,69 and
fish70cell systems, up-regulation of sparc expression in zebrafish
cells is contradictory to previous expression data in gilthead
seabream bone-derived VSa16 cells.71 qPCR data are however
consistent with immunocytochemistry data showing a stimu-
lated production of Spp1 and Sparc in the ECM of ZFB1 cells
undergoing mineralization. Type X collagen (Col10a1) is
a structural protein of the ECM essential for mineral nodule
deposition.72 While col10a1 expression is used as a marker for
chondrocyte hypertrophy in higher vertebrates,73,74 Avaron
et al.75 andRenn andWinkler76 recently reported the expression
of col10a1 in early osteoblasts, during intramembranous and
perichondral ossification of fish bone and therefore suggested
that it could be a marker of pre-osteoblasts in teleost fish. Ex-
pression of col10a1was stable in control ZFB1 cells and strongly
up-regulated during differentiation (16.2-fold increase after 1
week of treatment) and in cells undergoing ECM mineraliza-
tion (14,700-fold increase after 3 weeks of treatment, respec-
tively). Thus, expression data related to col10a1 pointed
towards an osteoblastic differentiation of ZFB1 chondro/
osteoblast progenitor cells upon exposure to mineralogenic
cocktail. Type II collagen, a homotrimer of the a1(II) chain
(Col2a1), is amajor protein of cartilage ECM and is synthesized
primarily by proliferating chondrocytes but not by hypertro-
phic chondrocytes.77 Upon exposure to mineralogenic cocktail,
col2a1 expression was down-regulated (about 5-fold decrease)
in differentiating (not significantly different from control cells)
FIG. 4. Real-time PCR analysis of bone-related genes in
ZFB1 cells treated for 3 weeks with osteoblastic cocktail. alp,
alkaline phosphatase; sox9a, SRY (sex determining region Y)–
box9; runx2, runt-related transcription factor 2; osx, osterix;
spp1, osteopontin; sparc, osteonectin; col10a1, type X collagen;
col2a1, type II collagen. C: control cultures; M: mineralizing
cultures. Values are presented as mean– standard deviation
calculated from three biological replicates (the value of each
biological replicate is the mean of at least three technical
replicates). Asterisks indicate values statistically significant
from T0 and cardinals indicate values statistically significant
from mineralization and control (one-way ANOVA p< 0.05).
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andmineralizing (20.9-fold decrease after 3weeks of treatment)
cultures. Expression data are consistent with immunocyto-
chemistry data, where Col2a1 was detected in few cells at
the sites of condensation during the ECM mineralization (Fig.
3E) and further confirm that ZFB1 cells do not differentiate
towards a chondroblast phenotype upon exposure to miner-
alogenic cocktail. Sox9 is a transcription factor with a high-
mobility-group (HMG-box) DNA-binding domain exhibiting a
high degree of homology with that of the mammalian testis-
determining factor, SRY. It was reported that during chon-
drogenesis, sox9 is expressed in all chondroprogenitors and
all differentiated chondrocytes.78–80 In ZFB1 cells, expression
of sox9a remained low and was not regulated during cell dif-
ferentiation and ECM mineralization thus further exclud-
ing chondrogenic differentiation, while qPCR analysis of
osteoblast marker gene expression revealed the up-regulation
of osteoblast-specific transcription factors (runx2 and osx), non-
collagenous ECM proteins (spp1 and sparc), and fibrilar colla-
gen (col10a1) demonstrating the osteoblastic potential of ZFB1.
Conclusions
This is the first report of the successful development of a
bone-derived stable cell culture from zebrafish. Our results
clearly show the presence within the ZFB1 cell population
of cells able to differentiate into two different bone lineages,
that is, chondroblast and osteoblast, with the capability of
ECM mineralization. ZFB1 cells represent the first zebrafish-
derived cell model with such characteristics. As detailed
above, the ZFB1 cells are cultured and manipulated using
regular reagents (medium and serum) and methods (cryo-
preservation and transfection), and thus its use can be easily
implemented in virtually any laboratory equipped with cell
culture facilities. The availability of such in vitro cell systems
represents a promising model for investigating bone lineage
cell differentiation in fish and will contribute to promote the
use of zebrafish as a model organism to study specific path-
ways involved in human skeletal-related diseases.
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